1. Home
  2. CLWT vs RNAZ Comparison

CLWT vs RNAZ Comparison

Compare CLWT & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLWT
  • RNAZ
  • Stock Information
  • Founded
  • CLWT 1971
  • RNAZ 2016
  • Country
  • CLWT Hong Kong
  • RNAZ United States
  • Employees
  • CLWT N/A
  • RNAZ N/A
  • Industry
  • CLWT Professional and commerical equipment
  • RNAZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLWT Consumer Discretionary
  • RNAZ Health Care
  • Exchange
  • CLWT Nasdaq
  • RNAZ Nasdaq
  • Market Cap
  • CLWT 9.4M
  • RNAZ 8.7M
  • IPO Year
  • CLWT 1997
  • RNAZ 2021
  • Fundamental
  • Price
  • CLWT $1.18
  • RNAZ $9.28
  • Analyst Decision
  • CLWT
  • RNAZ Strong Buy
  • Analyst Count
  • CLWT 0
  • RNAZ 1
  • Target Price
  • CLWT N/A
  • RNAZ $280.00
  • AVG Volume (30 Days)
  • CLWT 5.5K
  • RNAZ 16.5K
  • Earning Date
  • CLWT 12-29-2025
  • RNAZ 11-14-2025
  • Dividend Yield
  • CLWT N/A
  • RNAZ N/A
  • EPS Growth
  • CLWT N/A
  • RNAZ N/A
  • EPS
  • CLWT 0.10
  • RNAZ N/A
  • Revenue
  • CLWT $15,383,000.00
  • RNAZ N/A
  • Revenue This Year
  • CLWT N/A
  • RNAZ N/A
  • Revenue Next Year
  • CLWT N/A
  • RNAZ N/A
  • P/E Ratio
  • CLWT $11.83
  • RNAZ N/A
  • Revenue Growth
  • CLWT N/A
  • RNAZ N/A
  • 52 Week Low
  • CLWT $1.01
  • RNAZ $6.15
  • 52 Week High
  • CLWT $1.63
  • RNAZ $468.44
  • Technical
  • Relative Strength Index (RSI)
  • CLWT 39.03
  • RNAZ 36.61
  • Support Level
  • CLWT $1.10
  • RNAZ $8.41
  • Resistance Level
  • CLWT $1.21
  • RNAZ $9.43
  • Average True Range (ATR)
  • CLWT 0.05
  • RNAZ 0.58
  • MACD
  • CLWT -0.00
  • RNAZ -0.10
  • Stochastic Oscillator
  • CLWT 6.67
  • RNAZ 20.91

About CLWT Euro Tech Holdings Company Limited

Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

Share on Social Networks: